The efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase.
M. Gencoglu (Ankara, Turkey), G. Tugcu (Ankara, Turkey), S. Akyan Soydas (Ankara, Turkey), G. Cinel (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), E. Yalçin (Ankara, Turkey), N. Kiper (Ankara, Turkey), V. Sen (Diyarbakir, Turkey), D. Ufuk Altintas (Adana, Turkey), H. Çokugras (Istanbul, Turkey), A. Ayzit Kilinç (Istanbul, Turkey), H. Yazan (Istanbul, Turkey), G. Ünal (Konya, Turkey), . Yilmaz (Konya, Turkey), H. Çaglar (Konya, Turkey), E. Damadoglu (Ankara, Turkey), I. Irmak (Ankara, Turkey), . Demir (Izmir, Turkey), G. Öztürk (Izmir, Turkey), . Bingöl (Antalya, Turkey), E. Basaran (Antalya, Turkey), N. Sapan (Bursa, Turkey), A. Aslan (Ankara, Turkey), P. Asfuroglu (Ankara, Turkey), K. Harmanci (Eskisehir, Turkey), . Köse (Kayseri, Turkey), M. Hangül (Kayseri, Turkey), A. Özdemir (Mersin, Turkey), . Özcan (Ankara, Turkey), Z. Gayretli (Trabzon, Turkey), . Keskin (Gaziantep, Turkey), H. Yüksel (Manisa, Turkey), S. Özdogan (Istanbul, Turkey), . Topal (Malatya, Turkey), G. Çaltepe (Samsun, Turkey), . Can (Balikesir, Turkey), P. Korkmaz Ekren (Izmir, Turkey), M. Kiliç (Elazig, Turkey), . Sismanlar Eyüboglu (Ankara, Turkey), . Pekcan (Konya, Turkey), N. Çobanoglu (Ankara, Turkey), . Çakir (Istanbul, Turkey), U. Özçelik (Ankar, Turkey), D. Dogru (Ankar, Turkey)
Source: International Congress 2022 – Assessment and follow-up of cystic fibrosis lung disease in children
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gencoglu (Ankara, Turkey), G. Tugcu (Ankara, Turkey), S. Akyan Soydas (Ankara, Turkey), G. Cinel (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), E. Yalçin (Ankara, Turkey), N. Kiper (Ankara, Turkey), V. Sen (Diyarbakir, Turkey), D. Ufuk Altintas (Adana, Turkey), H. Çokugras (Istanbul, Turkey), A. Ayzit Kilinç (Istanbul, Turkey), H. Yazan (Istanbul, Turkey), G. Ünal (Konya, Turkey), . Yilmaz (Konya, Turkey), H. Çaglar (Konya, Turkey), E. Damadoglu (Ankara, Turkey), I. Irmak (Ankara, Turkey), . Demir (Izmir, Turkey), G. Öztürk (Izmir, Turkey), . Bingöl (Antalya, Turkey), E. Basaran (Antalya, Turkey), N. Sapan (Bursa, Turkey), A. Aslan (Ankara, Turkey), P. Asfuroglu (Ankara, Turkey), K. Harmanci (Eskisehir, Turkey), . Köse (Kayseri, Turkey), M. Hangül (Kayseri, Turkey), A. Özdemir (Mersin, Turkey), . Özcan (Ankara, Turkey), Z. Gayretli (Trabzon, Turkey), . Keskin (Gaziantep, Turkey), H. Yüksel (Manisa, Turkey), S. Özdogan (Istanbul, Turkey), . Topal (Malatya, Turkey), G. Çaltepe (Samsun, Turkey), . Can (Balikesir, Turkey), P. Korkmaz Ekren (Izmir, Turkey), M. Kiliç (Elazig, Turkey), . Sismanlar Eyüboglu (Ankara, Turkey), . Pekcan (Konya, Turkey), N. Çobanoglu (Ankara, Turkey), . Çakir (Istanbul, Turkey), U. Özçelik (Ankar, Turkey), D. Dogru (Ankar, Turkey). The efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase.. 2500
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|